By age 50, BPH is the most common prostate problem men face. The prostate enlarges, squeezes the urethra, and suddenly urination becomes a daily struggle. Medication helps in mild cases, but when symptoms get worse, minimally invasive procedures can restore normal flow — no major surgery required. Here’s what those options look like. keep reading

For decades, men have faced a coin flip after a high PSA result: biopsy or nothing. A major study of nearly 18,000 men suggests there's a smarter middle step — MRI. Used as a filter between PSA and biopsy, it identifies who truly needs further evaluation and cuts unnecessary overtreatment in half. keep reading

Your prostate has a secret line of defense that scientists only just discovered. Specialized immune cells called T cells travel to the prostate and stay there for months or years, standing guard against infection. Now researchers believe the same process that protects mouse prostates may apply to humans, and it could open a new door in prostate cancer treatment. keep reading

A New York Times reporter did solid work exposing the harms of PSA overscreening but missed something important. Between radical treatment and watchful waiting sits focal therapy: a minimally invasive, targeted option that the NCCN now recognizes, and that mpMRI makes more precise than ever. keep reading

Focal therapy destroys a prostate tumor while leaving healthy tissue intact. But once treatment is done, how do doctors know if it worked? A structured follow-up protocol using mpMRI is the current standard. Now a newly proposed PSMA-based scoring system called PSMA-FAB is aiming to complement that approach. keep reading

One in three men on Active Surveillance eventually stops, not because their cancer worsened, but because of fear. A new study suggests better imaging could change that. Researchers found that combining mpMRI with PSMA-PET nearly doubled detection rates for clinically significant prostate cancer, and helped 18% of patients avoid an unnecessary biopsy. keep reading

What if the very cells meant to protect your body are being hijacked to shield a tumor? In metastatic prostate cancer, that's exactly what can happen. Researchers are now launching a clinical trial to test whether combining radiation with targeted immune drugs can break through this defense and potentially point the way toward a cure. keep reading

A prostate MRI can detect cancer without contrast but how confident can a doctor be? DCE-MRI adds a third layer of information by capturing tumor blood flow patterns that plain MRI can't show. Gadolinium makes this possible, and modern formulations have an impressive safety record: over 170 million doses studied. keep reading

A high PSA result sounds alarming but it doesn't automatically mean cancer. Other factors can raise PSA, and until recently, the only way to know more was a biopsy. Now, two major breakthroughs are reshaping prostate cancer screening in ways that protect men from unnecessary procedures. keep reading

For men dealing with BPH, the urinary symptoms are just part of the story. The condition is now linked to measurable increases in depression and anxiety. Focal laser ablation at Sperling Prostate Center precisely reduces obstructing prostate tissue, helping men reclaim both their health and their wellbeing. keep reading